Feng Fang

发表

Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer.

Simon M. Lin, Pan Du, C. Clevenger, 2009, The American journal of pathology.

The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling

J. Varga, Jiucun Wang, M. Hinchcliff, 2015, Arthritis & rheumatology.

Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.

G. Mutlu, R. Lafyatis, S. Bhattacharyya, 2013, The American journal of pathology.

Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter

C. Clevenger, Jiamao Zheng, Feng Fang, 2008, BMC biotechnology.

Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro.

Chiang-Ching Huang, S. Bhattacharyya, J. Varga, 2012, Clinical and experimental rheumatology.

The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy

S. Bhattacharyya, J. Varga, B. Ye, 2012, Arthritis Research & Therapy.

Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy.

W. Tourtellotte, Minghua Wu, S. Bhattacharyya, 2011, Matrix biology : journal of the International Society for Matrix Biology.

Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells.

R. Atit, M. Whitfield, J. Varga, 2012, Arthritis and rheumatism.

The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic target

J. Varga, Wenxia Wang, Feng Fang, 2017, Oncotarget.

Autocrine IFN Signaling Inducing Profibrotic Fibroblast Responses by A Synthetic TLR3 Ligand Mitigates

S. Bhattacharyya, J. Varga, Feng Fang, 2013 .

Egr‐1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)

W. Tourtellotte, S. Bhattacharyya, J. Varga, 2013, The Journal of pathology.

Early growth response-2 expression in uterine leiomyoma cells: regulation and function.

J. Coon, P. Yin, S. Bulun, 2011, Fertility and sterility.

Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells.

Traci Galbaugh, A. Fiorillo, C. Clevenger, 2010, Journal of molecular endocrinology.

Toll‐like Receptor 9 Signaling Is Augmented in Systemic Sclerosis and Elicits Transforming Growth Factor β–Dependent Fibroblast Activation

W. Tourtellotte, S. Bhattacharyya, J. Varga, 2016, Arthritis & rheumatology.

A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Inducing Autocrine IFN Signaling

S. Bhattacharyya, J. Varga, Xiaoyong Sun, 2013, The Journal of Immunology.

Quantification of PRL / Stat 5 signaling with a novel pGL 4-CISH reporter

C. Clevenger, Jiamao Zheng, Feng Fang, 2015 .

From Bench to Bedside: Future Potential for the Translation of Prolactin Inhibitors as Breast Cancer Therapeutics

Traci Galbaugh, C. Clevenger, Elizabeth M. Jablonski, 2008, Journal of Mammary Gland Biology and Neoplasia.

Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.

C. Clevenger, Feng Fang, Feng Fang, 2009, Endocrinology.

The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses.

Swati Bhattacharyya, John Varga, Minghua Wu, 2011, The American journal of pathology.

An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis

J. Varga, Y. Asano, T. Taniguchi, 2018, Scientific Reports.

Negative cross talk between NFAT1 and Stat5 signaling in breast cancer.

A. Fiorillo, C. Clevenger, Jiamao Zheng, 2011, Molecular endocrinology.

Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target

W. Tourtellotte, L. Otvos, J. Varga, 2017, Scientific Reports.

JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.

Dong Chen, Serdar E Bulun, S. Bulun, 2011, Molecular endocrinology.